Apellis Pharmaceuticals, Inc. (APLS)
22.05
-0.26
(-1.17%)
USD |
NASDAQ |
Feb 12, 16:00
21.96
-0.09
(-0.41%)
Pre-Market: 09:21
Apellis Pharmaceuticals Free Cash Flow : 78.64M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amneal Pharmaceuticals, Inc. | 236.43M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Amicus Therapeutics, Inc. | 9.691M |
| Ionis Pharmaceuticals, Inc. | -309.48M |
| Sarepta Therapeutics, Inc. | -401.63M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 108.47M |
| Cash from Investing (Quarterly) | -0.148M |
| Cash from Financing (Quarterly) | 0.793M |
| Free Cash Flow Per Share (Quarterly) | 0.8328 |
| Free Cash Flow to Equity (Quarterly) | 102.71M |
| Free Cash Flow to Firm (Quarterly) | 119.57M |
| Free Cash Flow Yield | 2.82% |